...
search icon
dxcm-img

DexCom Inc, Common Stock

DXCM

NSQ

$61.8

-$6.34

(-9.3%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$24.76B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
47.9859
Volume info-icon
This is the total number of shares traded during the most recent trading day.
5.40M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.29
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$62.34 L
$141.99 H
$61.8

About DexCom Inc, Common Stock

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameDXCMSectorS&P500
1-Week Return-11.04%-0.46%-0.44%
1-Month Return-28.13%-3.53%-3.35%
3-Month Return-23.77%3.84%-4.68%
6-Month Return-5.91%-4.77%-0.56%
1-Year Return-55.38%0.19%8.7%
3-Year Return-52.66%5.39%23.59%
5-Year Return-5.2%66.28%127.57%
10-Year Return290.03%100.14%172.42%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue1.93B2.45B2.91B3.62B4.03B[{"date":"2020-12-31","value":47.77,"profit":true},{"date":"2021-12-31","value":60.71,"profit":true},{"date":"2022-12-31","value":72.15,"profit":true},{"date":"2023-12-31","value":89.82,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue646.60M768.00M1.03B1.33B1.57B[{"date":"2020-12-31","value":41.26,"profit":true},{"date":"2021-12-31","value":49,"profit":true},{"date":"2022-12-31","value":65.51,"profit":true},{"date":"2023-12-31","value":85.08,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit1.28B1.68B1.88B2.29B2.47B[{"date":"2020-12-31","value":51.92,"profit":true},{"date":"2021-12-31","value":68.16,"profit":true},{"date":"2022-12-31","value":76.37,"profit":true},{"date":"2023-12-31","value":92.83,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin66.44%68.63%64.72%63.19%61.14%[{"date":"2020-12-31","value":96.8,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.29,"profit":true},{"date":"2023-12-31","value":92.07,"profit":true},{"date":"2024-12-31","value":89.08,"profit":true}]
Operating Expenses980.60M1.41B1.49B1.69B1.87B[{"date":"2020-12-31","value":52.56,"profit":true},{"date":"2021-12-31","value":75.83,"profit":true},{"date":"2022-12-31","value":79.96,"profit":true},{"date":"2023-12-31","value":90.65,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income299.50M175.40M391.20M597.70M600.00M[{"date":"2020-12-31","value":49.92,"profit":true},{"date":"2021-12-31","value":29.23,"profit":true},{"date":"2022-12-31","value":65.2,"profit":true},{"date":"2023-12-31","value":99.62,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(143.10M)(109.30M)(19.00M)227.40M224.20M[{"date":"2020-12-31","value":-62.93,"profit":false},{"date":"2021-12-31","value":-48.07,"profit":false},{"date":"2022-12-31","value":-8.36,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":98.59,"profit":true}]
Pre-Tax Income225.00M173.90M390.80M710.40M709.00M[{"date":"2020-12-31","value":31.67,"profit":true},{"date":"2021-12-31","value":24.48,"profit":true},{"date":"2022-12-31","value":55.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":99.8,"profit":true}]
Income Taxes(268.60M)19.20M49.60M168.90M132.80M[{"date":"2020-12-31","value":-159.03,"profit":false},{"date":"2021-12-31","value":11.37,"profit":true},{"date":"2022-12-31","value":29.37,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":78.63,"profit":true}]
Income After Taxes493.60M154.70M341.20M541.50M576.20M[{"date":"2020-12-31","value":85.66,"profit":true},{"date":"2021-12-31","value":26.85,"profit":true},{"date":"2022-12-31","value":59.22,"profit":true},{"date":"2023-12-31","value":93.98,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations493.60M154.70M341.20M541.50M576.20M[{"date":"2020-12-31","value":85.66,"profit":true},{"date":"2021-12-31","value":26.85,"profit":true},{"date":"2022-12-31","value":59.22,"profit":true},{"date":"2023-12-31","value":93.98,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income493.60M154.70M341.20M541.50M576.20M[{"date":"2020-12-31","value":85.66,"profit":true},{"date":"2021-12-31","value":26.85,"profit":true},{"date":"2022-12-31","value":59.22,"profit":true},{"date":"2023-12-31","value":93.98,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)0.780.660.871.511.65[{"date":"2020-12-31","value":47.27,"profit":true},{"date":"2021-12-31","value":40,"profit":true},{"date":"2022-12-31","value":52.73,"profit":true},{"date":"2023-12-31","value":91.52,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

DXCM
Cash Ratio 0.88
Current Ratio 1.47
Quick Ratio 1.28

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DXCM
ROA (LTM) 5.88%
ROE (LTM) 27.63%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DXCM
Debt Ratio Lower is generally better. Negative is bad. 0.68
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.32

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DXCM
Trailing PE 47.99
Forward PE 33.44
P/S (TTM) 6.62
P/B 12.55
Price/FCF 151
EV/R 6.55
EV/Ebitda 27.92
PEG 1.07

FAQs

What is DexCom Inc share price today?

DexCom Inc (DXCM) share price today is $61.8

Can Indians buy DexCom Inc shares?

Yes, Indians can buy shares of DexCom Inc (DXCM) on Vested. To buy DexCom Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DXCM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of DexCom Inc be purchased?

Yes, you can purchase fractional shares of DexCom Inc (DXCM) via the Vested app. You can start investing in DexCom Inc (DXCM) with a minimum investment of $1.

How to invest in DexCom Inc shares from India?

You can invest in shares of DexCom Inc (DXCM) via Vested in three simple steps:

  • Click on Sign Up or Invest in DXCM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in DexCom Inc shares
What is DexCom Inc 52-week high and low stock price?

The 52-week high price of DexCom Inc (DXCM) is $141.99. The 52-week low price of DexCom Inc (DXCM) is $62.34.

What is DexCom Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of DexCom Inc (DXCM) is 47.9859

What is DexCom Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of DexCom Inc (DXCM) is 12.55

What is the Market Cap of DexCom Inc?

The market capitalization of DexCom Inc (DXCM) is $24.76B

What is DexCom Inc’s stock symbol?

The stock symbol (or ticker) of DexCom Inc is DXCM

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top